• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中性粒细胞胞外诱捕网与慢性阻塞性肺疾病患者的疾病严重程度和微生物多样性有关。

Neutrophil extracellular traps are associated with disease severity and microbiota diversity in patients with chronic obstructive pulmonary disease.

机构信息

Scottish Centre for Respiratory Research, University of Dundee, Ninewells Hospital and Medical School, Dundee, United Kingdom.

Respiratory Department, Hospital de la Santa Creu i Sant Pau, Institut d'Invesitgacio Biomedica (IIB) Sant Pau, Barcelona, Spain.

出版信息

J Allergy Clin Immunol. 2018 Jan;141(1):117-127. doi: 10.1016/j.jaci.2017.04.022. Epub 2017 May 13.

DOI:10.1016/j.jaci.2017.04.022
PMID:28506850
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5751731/
Abstract

BACKGROUND

Neutrophil extracellular traps (NETs) have been observed in the airway in patients with chronic obstructive pulmonary disease (COPD), but their clinical and pathophysiologic implications have not been defined.

OBJECTIVE

We sought to determine whether NETs are associated with disease severity in patients with COPD and how they are associated with microbiota composition and airway neutrophil function.

METHODS

NET protein complexes (DNA-elastase and histone-elastase complexes), cell-free DNA, and neutrophil biomarkers were quantified in soluble sputum and serum from patients with COPD during periods of disease stability and during exacerbations and compared with clinical measures of disease severity and the sputum microbiome. Peripheral blood and airway neutrophil function were evaluated by means of flow cytometry ex vivo and experimentally after stimulation of NET formation.

RESULTS

Sputum NET complexes were associated with the severity of COPD evaluated by using the composite Global Initiative for Obstructive Lung Disease scale (P < .0001). This relationship was due to modest correlations between NET complexes and FEV, symptoms evaluated by using the COPD assessment test, and higher levels of NET complexes in patients with frequent exacerbations (P = .002). Microbiota composition was heterogeneous, but there was a correlation between NET complexes and both microbiota diversity (P = .009) and dominance of Haemophilus species operational taxonomic units (P = .01). Ex vivo airway neutrophil phagocytosis of bacteria was reduced in patients with increased sputum NET complexes. Consistent results were observed regardless of the method of quantifying sputum NETs. Failure of phagocytosis could be induced experimentally by incubating healthy control neutrophils with soluble sputum from patients with COPD.

CONCLUSION

NET formation is increased in patients with severe COPD and associated with more frequent exacerbations and a loss of microbiota diversity.

摘要

背景

在慢性阻塞性肺疾病(COPD)患者的气道中观察到中性粒细胞胞外陷阱(NETs),但其临床和病理生理意义尚未确定。

目的

我们旨在确定 NET 是否与 COPD 患者的疾病严重程度相关,以及它们与微生物群组成和气道中性粒细胞功能的关系。

方法

在 COPD 患者疾病稳定期和加重期测量可溶性痰和血清中的 NET 蛋白复合物(DNA-弹性蛋白酶和组蛋白-弹性蛋白酶复合物)、无细胞 DNA 和中性粒细胞生物标志物,并与疾病严重程度的临床指标和痰微生物组进行比较。通过体外流式细胞术和 NET 形成刺激后的实验评估外周血和气道中性粒细胞功能。

结果

痰 NET 复合物与使用综合全球倡议阻塞性肺病量表评估的 COPD 严重程度相关(P<0.0001)。这种关系归因于 NET 复合物与 FEV、COPD 评估测试评估的症状之间的适度相关性,以及频繁加重的患者 NET 复合物水平较高(P=0.002)。微生物群组成存在异质性,但 NET 复合物与微生物群多样性(P=0.009)和 Haemophilus 种操作分类单位的优势(P=0.01)之间存在相关性。在痰 NET 复合物增加的患者中,气道中性粒细胞对细菌的吞噬作用降低。无论采用何种方法定量痰 NET,都观察到一致的结果。通过用 COPD 患者的可溶性痰孵育健康对照中性粒细胞,可在实验中诱导吞噬作用失败。

结论

严重 COPD 患者的 NET 形成增加,与更频繁的加重和微生物群多样性丧失有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e40/5751731/4e40c6fa27ab/figs9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e40/5751731/359f54723d6e/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e40/5751731/216dcefddda9/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e40/5751731/d3b1dd6f6534/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e40/5751731/451de30a1bf8/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e40/5751731/79be91fdc787/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e40/5751731/7cece46b5412/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e40/5751731/152ccb1f4476/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e40/5751731/04a815f7ebcf/figs1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e40/5751731/062f3bf1da0e/figs2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e40/5751731/5480531694e6/figs3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e40/5751731/de16017b446d/figs4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e40/5751731/60caafac5c39/figs5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e40/5751731/d57fde226062/figs6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e40/5751731/5539faf7c662/figs7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e40/5751731/102c36b80ac2/figs8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e40/5751731/4e40c6fa27ab/figs9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e40/5751731/359f54723d6e/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e40/5751731/216dcefddda9/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e40/5751731/d3b1dd6f6534/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e40/5751731/451de30a1bf8/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e40/5751731/79be91fdc787/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e40/5751731/7cece46b5412/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e40/5751731/152ccb1f4476/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e40/5751731/04a815f7ebcf/figs1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e40/5751731/062f3bf1da0e/figs2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e40/5751731/5480531694e6/figs3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e40/5751731/de16017b446d/figs4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e40/5751731/60caafac5c39/figs5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e40/5751731/d57fde226062/figs6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e40/5751731/5539faf7c662/figs7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e40/5751731/102c36b80ac2/figs8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e40/5751731/4e40c6fa27ab/figs9.jpg

相似文献

1
Neutrophil extracellular traps are associated with disease severity and microbiota diversity in patients with chronic obstructive pulmonary disease.中性粒细胞胞外诱捕网与慢性阻塞性肺疾病患者的疾病严重程度和微生物多样性有关。
J Allergy Clin Immunol. 2018 Jan;141(1):117-127. doi: 10.1016/j.jaci.2017.04.022. Epub 2017 May 13.
2
Sputum Microbiome, Potentially Pathogenic Organisms, and Clinical Outcomes in Japanese Patients with COPD and Moderate Airflow Limitation: The Prospective AERIS-J Study.日本慢性阻塞性肺疾病(COPD)合并中度气流受限患者的痰液微生物组、潜在致病生物与临床结局:前瞻性AERIS-J研究
Int J Chron Obstruct Pulmon Dis. 2025 May 14;20:1477-1492. doi: 10.2147/COPD.S481406. eCollection 2025.
3
The sputum microbiome, airway inflammation, and mortality in chronic obstructive pulmonary disease.慢性阻塞性肺疾病的痰微生物组、气道炎症与死亡率。
J Allergy Clin Immunol. 2021 Jan;147(1):158-167. doi: 10.1016/j.jaci.2020.02.040. Epub 2020 Apr 28.
4
Neutrophil extracellular traps are associated with inflammation in chronic airway disease.中性粒细胞胞外诱捕网与慢性气道疾病中的炎症相关。
Respirology. 2016 Apr;21(3):467-75. doi: 10.1111/resp.12730. Epub 2016 Jan 25.
5
Inflammatory Endotype-associated Airway Microbiome in Chronic Obstructive Pulmonary Disease Clinical Stability and Exacerbations: A Multicohort Longitudinal Analysis.慢性阻塞性肺疾病临床稳定期和加重期的炎症表型相关气道微生物组:一项多队列纵向分析。
Am J Respir Crit Care Med. 2021 Jun 15;203(12):1488-1502. doi: 10.1164/rccm.202009-3448OC.
6
Neutrophil extracellular trap formation and extracellular DNA in sputum of stable COPD patients.稳定期慢性阻塞性肺疾病患者痰液中的中性粒细胞胞外诱捕网形成及细胞外DNA
Respir Med. 2015 Oct;109(10):1360-2. doi: 10.1016/j.rmed.2015.08.008. Epub 2015 Aug 22.
7
Inhibition of neutrophil elastase prevents cigarette smoke exposure-induced formation of neutrophil extracellular traps and improves lung function in a mouse model of chronic obstructive pulmonary disease.抑制中性粒细胞弹性蛋白酶可预防香烟烟雾暴露诱导的中性粒细胞胞外陷阱形成,并改善慢性阻塞性肺疾病小鼠模型的肺功能。
Int Immunopharmacol. 2023 Jan;114:109537. doi: 10.1016/j.intimp.2022.109537. Epub 2022 Dec 7.
8
New aspects on the structure of neutrophil extracellular traps from chronic obstructive pulmonary disease and in vitro generation.慢性阻塞性肺疾病中性粒细胞胞外诱捕网结构及体外生成的新进展
PLoS One. 2014 May 15;9(5):e97784. doi: 10.1371/journal.pone.0097784. eCollection 2014.
9
Chronic obstructive pulmonary disease upper airway microbiota alpha diversity is associated with exacerbation phenotype: a case-control observational study.慢性阻塞性肺疾病上呼吸道微生物群落 α 多样性与加重表型相关:一项病例对照观察性研究。
Respir Res. 2019 Jun 7;20(1):114. doi: 10.1186/s12931-019-1080-4.
10
Neutrophil extracellular trap (NET) formation characterises stable and exacerbated COPD and correlates with airflow limitation.中性粒细胞胞外诱捕网(NET)形成是稳定期和加重期慢性阻塞性肺疾病(COPD)的特征,且与气流受限相关。
Respir Res. 2015 May 22;16(1):59. doi: 10.1186/s12931-015-0221-7.

引用本文的文献

1
Next-Generation Regenerative Therapies for Alpha-1 Antitrypsin Deficiency: Molecular Pathogenesis to Clinical Translation.α-1抗胰蛋白酶缺乏症的下一代再生疗法:从分子发病机制到临床转化
Int J Mol Sci. 2025 Sep 1;26(17):8504. doi: 10.3390/ijms26178504.
2
Construction and validation of a prediction model for developing type 2 diabetes mellitus in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者发生2型糖尿病预测模型的构建与验证
Front Endocrinol (Lausanne). 2025 Aug 15;16:1560631. doi: 10.3389/fendo.2025.1560631. eCollection 2025.
3
Pulmonary Hypertension Secondary to Fungal Infections: Underexplored Pathological Links.

本文引用的文献

1
Blood eosinophils and inhaled corticosteroid/long-acting β-2 agonist efficacy in COPD.血液嗜酸性粒细胞与慢性阻塞性肺疾病中吸入性糖皮质激素/长效β-2受体激动剂的疗效
Thorax. 2016 Feb;71(2):118-25. doi: 10.1136/thoraxjnl-2015-207021. Epub 2015 Nov 19.
2
Neutrophil extracellular trap formation and extracellular DNA in sputum of stable COPD patients.稳定期慢性阻塞性肺疾病患者痰液中的中性粒细胞胞外诱捕网形成及细胞外DNA
Respir Med. 2015 Oct;109(10):1360-2. doi: 10.1016/j.rmed.2015.08.008. Epub 2015 Aug 22.
3
Exploring Different Phenotypes of COPD.探索慢性阻塞性肺疾病的不同表型。
真菌感染继发的肺动脉高压:未充分探索的病理联系
Infect Dis Rep. 2025 Jul 12;17(4):84. doi: 10.3390/idr17040084.
4
Extracellular Traps in Inflammation: Pathways and Therapeutic Targets.炎症中的细胞外陷阱:途径与治疗靶点
Life (Basel). 2025 Apr 8;15(4):627. doi: 10.3390/life15040627.
5
Transcriptomic and metabolomic insights into neutrophil activity in COPD complicated by metabolic syndrome.慢性阻塞性肺疾病合并代谢综合征中中性粒细胞活性的转录组学和代谢组学见解
Biomed Eng Online. 2025 Apr 15;24(1):43. doi: 10.1186/s12938-025-01378-5.
6
Safety, tolerability, pharmacokinetics and pharmacodynamics of HSK31858, a novel oral dipeptidyl peptidase-1 inhibitor, in healthy volunteers: An integrated phase 1, randomized, double-blind, placebo-controlled, single- and multiple-ascending dose study.新型口服二肽基肽酶-1抑制剂HSK31858在健康志愿者中的安全性、耐受性、药代动力学和药效学:一项整合的1期随机、双盲、安慰剂对照、单剂量和多剂量递增研究。
Br J Clin Pharmacol. 2025 Aug;91(8):2262-2272. doi: 10.1002/bcp.70027. Epub 2025 Apr 2.
7
Use of inhaled corticosteroids in bronchiectasis: data from the European Bronchiectasis Registry (EMBARC).吸入性糖皮质激素在支气管扩张症中的应用:来自欧洲支气管扩张症注册研究(EMBARC)的数据。
Thorax. 2025 May 20;80(6):358-368. doi: 10.1136/thorax-2024-221825.
8
Inhibition of 5-hydroxyindoleacetic acid to reduce neutrophil extracellular trap production improves lung condition in chronic obstructive pulmonary disease mice.抑制5-羟吲哚乙酸以减少中性粒细胞胞外陷阱生成可改善慢性阻塞性肺疾病小鼠的肺部状况。
Ann Med. 2025 Dec;57(1):2474734. doi: 10.1080/07853890.2025.2474734. Epub 2025 Mar 11.
9
Immunological Insights and Therapeutic Advances in COPD: Exploring Oral Bacterial Vaccines for Immune Modulation and Clinical Improvement.慢性阻塞性肺疾病的免疫学见解与治疗进展:探索用于免疫调节和临床改善的口服细菌疫苗
Vaccines (Basel). 2025 Jan 22;13(2):107. doi: 10.3390/vaccines13020107.
10
Lung Microbiota: From Healthy Lungs to Development of Chronic Obstructive Pulmonary Disease.肺微生物群:从健康肺脏到慢性阻塞性肺疾病的发展
Int J Mol Sci. 2025 Feb 7;26(4):1403. doi: 10.3390/ijms26041403.
N Engl J Med. 2015 Jul 9;373(2):185-6. doi: 10.1056/NEJMe1503888.
4
Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease.导致慢性阻塞性肺疾病的肺功能轨迹。
N Engl J Med. 2015 Jul 9;373(2):111-22. doi: 10.1056/NEJMoa1411532.
5
Neutrophil extracellular trap (NET) formation characterises stable and exacerbated COPD and correlates with airflow limitation.中性粒细胞胞外诱捕网(NET)形成是稳定期和加重期慢性阻塞性肺疾病(COPD)的特征,且与气流受限相关。
Respir Res. 2015 May 22;16(1):59. doi: 10.1186/s12931-015-0221-7.
6
The inhibitory effect of secretory leukocyte protease inhibitor (SLPI) on formation of neutrophil extracellular traps.分泌型白细胞蛋白酶抑制剂(SLPI)对中性粒细胞胞外诱捕网形成的抑制作用。
J Leukoc Biol. 2015 Jul;98(1):99-106. doi: 10.1189/jlb.4AB1114-543R. Epub 2015 Apr 27.
7
Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials.血液嗜酸性粒细胞计数、加重情况以及慢性阻塞性肺疾病患者添加吸入氟替卡松维兰特罗后的反应:两项平行随机对照试验数据的二次分析。
Lancet Respir Med. 2015 Jun;3(6):435-42. doi: 10.1016/S2213-2600(15)00106-X. Epub 2015 Apr 12.
8
An Official American Thoracic Society/European Respiratory Society Statement: Research questions in chronic obstructive pulmonary disease.美国胸科学会/欧洲呼吸学会官方声明:慢性阻塞性肺疾病研究问题。
Am J Respir Crit Care Med. 2015 Apr 1;191(7):e4-e27. doi: 10.1164/rccm.201501-0044ST.
9
Impact of Left Ventricular Hypertrophy on Survival in Chronic Obstructive Pulmonary Disease.左心室肥厚对慢性阻塞性肺疾病患者生存的影响
Lung. 2015 Aug;193(4):487-95. doi: 10.1007/s00408-015-9724-8. Epub 2015 Mar 29.
10
Neutrophil extracellular traps are pathogenic in primary graft dysfunction after lung transplantation.中性粒细胞胞外诱捕网在肺移植术后原发性移植肺功能障碍中具有致病性。
Am J Respir Crit Care Med. 2015 Feb 15;191(4):455-63. doi: 10.1164/rccm.201406-1086OC.